AroCell AB

AROC - ST
Save to watchlist

Add to calculator

Compare stock
Overview
Stock analysis
Dividends
Fundamentals
AroCell AB
AROC
-
ST
Overview
Stock analysis
Dividends
Fundamentals

Overview

About stock

Health care
Sector
Diagnostics & Research
Industry

AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever.

The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006.

Similar stocks

Report issue